ANI Pharmaceuticals (NASDAQ:ANIP) is preparing to release its quarterly earnings on Friday, 2025-08-08. Here’s a brief overview of what investors should keep in mind before the announcement.
Analysts expect ANI Pharmaceuticals to report an earnings per share (EPS) of $1.26.
The market awaits ANI Pharmaceuticals’s announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It’s important for new investors to understand that guidance can be a significant driver of stock prices.
Past Earnings Performance
During the last quarter, the company reported an EPS beat by $1.76, leading to a 0.0% drop in the share price on the subsequent day.
Here’s a look at ANI Pharmaceuticals’s past performance and the resulting price change:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.06 | 0.29 | 1.09 | 0.94 |
| EPS Actual | 1.70 | 1.63 | 1.34 | 1.02 |
| Price Change % | -7.000000000000001% | 13.0% | 5.0% | -10.0% |
Tracking ANI Pharmaceuticals’s Stock Performance
Shares of ANI Pharmaceuticals were trading at $69.09 as of August 06. Over the last 52-week period, shares are up 20.57%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.
Analyst Observations about ANI Pharmaceuticals
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding ANI Pharmaceuticals.
A total of 2 analyst ratings have been received for ANI Pharmaceuticals, with the consensus rating being Buy. The average one-year price target stands at $85.0, suggesting a potential 23.03% upside.
Comparing Ratings with Peers
In this analysis, …